Quick Answer
OPKO HEALTH, INC. reported Cash and Equivalents of $95.88 million for fiscal year 2023.
OPKO HEALTH, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2023 | $95.88M | -37.4% |
| 2022 | $153.19M | +13.7% |
| 2021 | $134.71M | +86.6% |
| 2020 | $72.21M | -15.5% |
| 2019 | $85.45M | -11.4% |
| 2018 | $96.47M | +5.4% |
| 2017 | $91.50M | -45.8% |
| 2016 | $168.73M | -12.8% |
| 2015 | $193.60M | +99.8% |
| 2014 | $96.91M | -47.8% |
| 2013 | $185.80M | +579.1% |
| 2012 | $27.36M | -61.7% |
| 2011 | $71.52M | +297.0% |
| 2010 | $18.02M | -57.8% |
| 2009 | $42.66M | +538.8% |
| 2008 | $6.68M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| June 30, 2024 | $40.58M | -62.5% | -46.4% |
| March 31, 2024 | $75.64M | -31.8% | -21.1% |
| December 31, 2023 | $95.88M | -37.4% | -30.8% |
| September 30, 2023 | $138.62M | -23.3% | +28.2% |
| June 30, 2023 | $108.11M | -48.6% | -2.5% |
| March 31, 2023 | $110.83M | +8.4% | -27.7% |
| December 31, 2022 | $153.19M | +13.7% | -15.3% |
| September 30, 2022 | $180.84M | +21.7% | -14.1% |
- OPKO HEALTH, INC. showed a decrease of -37.4% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2023 period, OPKO HEALTH, INC.’s cash and equivalents has grown by 1335.8% (from $6.68 million to $95.88 million).
- The most recent figure is from OPKO HEALTH, INC.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 1, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: